Bicocca Open Archive

Logo unimib boa
ARCANGELI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.942
EU - Europa 2.618
AS - Asia 1.031
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 3
Totale 9.603
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.884
IT - Italia 676
IE - Irlanda 617
DE - Germania 465
SG - Singapore 398
SE - Svezia 316
CN - Cina 298
HK - Hong Kong 245
RU - Federazione Russa 198
GB - Regno Unito 117
UA - Ucraina 105
FR - Francia 58
CA - Canada 56
VN - Vietnam 38
FI - Finlandia 20
IN - India 20
ID - Indonesia 14
NL - Olanda 11
DK - Danimarca 10
TR - Turchia 9
CZ - Repubblica Ceca 7
IR - Iran 4
ES - Italia 3
EU - Europa 3
GR - Grecia 3
RO - Romania 3
SA - Arabia Saudita 3
SC - Seychelles 3
AT - Austria 2
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
NZ - Nuova Zelanda 1
PE - Perù 1
TH - Thailandia 1
Totale 9.603
Salva come PNG Salva come JPEG
Città #
Fairfield 1.047
Ann Arbor 823
Dublin 612
Ashburn 449
Frankfurt am Main 430
Woodbridge 429
Wilmington 402
Seattle 394
Singapore 360
Cambridge 341
Houston 341
Hong Kong 245
Princeton 237
New York 183
Milan 146
Chandler 122
Lawrence 108
Altamura 107
Santa Clara 100
Dearborn 89
Jacksonville 87
San Diego 69
Nanjing 67
Rome 45
Andover 41
Beijing 34
Shanghai 32
Toronto 28
Dong Ket 26
Ottawa 26
Hebei 24
Nanchang 22
Shenyang 22
London 21
Helsinki 18
Guangzhou 17
Jiaxing 14
Jakarta 12
Jinan 12
Lissone 12
Fremont 11
Pune 11
Redmond 10
Sulzano 10
Cologna Veneta 9
Munich 9
Norwalk 9
Changsha 8
Olomouc 7
Palermo 7
Anzio 6
Chicago 6
Los Angeles 6
Naples 6
Tianjin 6
Verona 6
Zhengzhou 6
Bari 5
Brescia 5
Cagliari 5
Huizen 5
Kiev 5
Monza 5
San Mateo 5
Berlin 4
Boardman 4
Chiswick 4
Falls Church 4
Fuzhou 4
Genoa 4
Hefei 4
Messina 4
Nave 4
Perugia 4
Amantea 3
Athens 3
Boulder 3
Bucharest 3
Dallas 3
Florence 3
Kocaeli 3
Leawood 3
Lonigo 3
Madrid 3
Mahé 3
Mountain View 3
Ningbo 3
Pisa 3
Southwark 3
Torino 3
Turin 3
Washington 3
Zanjan 3
Ankara 2
Antony 2
Azzano San Paolo 2
Bernareggio 2
Bollate 2
Carnago 2
Carovigno 2
Totale 7.873
Salva come PNG Salva come JPEG
Nome #
Effetti immunologici della radioterapia 350
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 255
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 244
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 237
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: A secondary analysis from a randomized study 189
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 176
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 169
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study 148
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials 146
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy 140
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 124
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer 122
Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer 120
GUROPA survey: genito-urinary radiation oncology prescription attitudes 113
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area 112
1539 poster TUMOR CONTROL PROBABILITY IN STEREOTACTIC RADIO-SURGERY FOR BRAIN METASTASES 112
DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans 109
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 109
Moderate hypofractionation in high-risk, organ-confined prostate cancer: Final results of a phase III randomized trial 108
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 108
Epidemiology of prostate cancer and treatment remarks. 107
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer 107
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer 106
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials 105
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 105
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial 103
Mathematical Model for Evaluating Incidence of Acute Rectal Toxicity During Conventional or Hypofractionated Radiotherapy Courses for Prostate Cancer 102
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 102
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group 102
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer 100
Moderate hypofractionation for prostate cancer 100
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC 100
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity 100
Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more? 99
Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours 98
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study 98
Postoperative Hypofractionated Radiotherapy for Prostate Cancer 97
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: A further step toward new evidence 97
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 97
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer 97
EORTC radiation proctitis-specific quality of life module - pretesting in four European countries 95
Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer 94
Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial 94
Extreme hypofractionation for early prostate cancer: Biology meets technology 93
Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI 93
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 92
Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study 92
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 91
Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? 91
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) 91
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 90
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease 90
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review. 89
Updated Results and Pattern of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer 89
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. 89
Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed 87
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO) 86
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery 85
Dose-escalated Radiotherapy for Stage III Unresectable Non-small Cell Lung Cancer: Have We Come to a Standstill? 85
Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture? 84
A Systematic Review of Radical Cystectomy Versus Organ Preserving Trimodal Therapy in Muscle-Invasive Bladder Cancer 84
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations 84
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. 84
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis. 84
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer 83
Re-irradiation for esophageal cancer 83
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. 83
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial 82
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 80
Hypofractionation and Stereotactic Treatment: Clinical Data 79
Review and uses of stereotactic body radiation therapy for oligometastases 78
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias 78
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control 78
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature 77
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 75
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments 75
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review 74
From radiobiology to technology: what is changing in radiotherapy for prostate cancer 73
Vertebral metastases reirradiation with volumetric-modulated arc radiotherapy 70
Is Hypofractionated (Chemo) radiation Delivered With Helical Tomotherapy a Feasible Option to Escalate the Dose in Locally- Advanced Inoperable NSCLC?: Results From a Phase 2 Trial 69
Radiation therapy of breast cancer. Reasoned approach to a clinical case 65
Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy 64
Safety culture to improve accidental event reporting in radiotherapy 64
Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 62
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 61
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 59
External beam radiation therapy in the treatment of the prostate adenocarcinoma in the elderly 58
Stereotactic Body Radiation Therapy With Ablative Dose on Liver Metastases: Radiation-induced Liver Disease (RILD) and Toxicity Assessment 56
Dose and volume as predictive factors of pulmonary toxicity 56
Guidelines on prostate carcinoma - AIRO, 2016 56
Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy 55
Single fraction partial breast irradiation in prone position 50
A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer: The LaIT-SABR Study 47
Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study 46
The role of palliative radiotherapy in the management of elderly and frail patients with advanced bladder cancer: A survey by the AIRO uro-group 45
Principi di Radioterapia 44
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 41
Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 40
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking 39
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 38
Totale 9.632
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.874
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.748 0 0 0 248 182 271 294 217 216 106 155 59
2020/20211.701 74 89 187 196 195 137 150 199 105 135 115 119
2021/20221.056 83 133 115 49 27 53 42 178 41 35 88 212
2022/20231.648 275 484 194 75 69 271 30 56 100 15 48 31
2023/20241.498 30 23 34 144 164 358 385 29 169 26 29 107
2024/2025887 146 581 159 1 0 0 0 0 0 0 0 0
Totale 10.264